NeOnc Technologies (Nasdaq: NTHI) Investor Conference Call to Present Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma Aug 12, 2026 8:30 AM EDT Click here for Webcast
NeOnc Technologies (Nasdaq: NTHI) Investor Conference Call to Present Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma Aug 12, 2026 8:30 AM EDT Click here for Webcast